DexCom (DXCM) Reiterated at Buy by Benchmark as Revenue Forecast Raised
Tweet Send to a Friend
Benchmark analyst Bruce Jackson reiterated a Buy rating and $77.00 price target on DexCom (NASDAQ: DXCM).The analyst commented, "For 2Q ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
